Clinical Trial: A Biomarker Screening Protocol for Participants With Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Triple Negative Breast Cancer
Study Type: OBSERVATIONAL
Official Title: A Biomarker Screening Protocol to Support Preliminary Eligibility for Clinical Trials Evaluating Safety and Efficacy of Adoptive T-cell Therapies in Participants With Solid Tumors
Brief Summary:
Biomarker Screening Protocol for Preliminary Eligibility Determination for Adoptive T-cell Therapy Trials:This is a decentralized, multi-site, US-based biomarker screening study to identify participants who have specific disease indications and tumor expression of target(s) of interest that may inform eligibility for active and future Lyell clinical trials.No investigational treatments will be administered in this non-interventional screening study.Only previously obtained archival tumor tissue will be allowed on…
Read more